Table 1. Baseline characteristics of the subjects.
Control group | SEP group | |||||
---|---|---|---|---|---|---|
|
|
|||||
M | F | Total | M | F | Total | |
n | 10 | 5 | 15 | 12 | 20 | 32 |
Age (yrs) | 26 ± 6.9 | 32 ± 10.4 | 28 ± 8.4 | 26 ± 6.8 | 27 ± 8.2 | 26.5 ± 7.6 |
Diabetes duration (min-max) (yrs) | 5-23 | 6-31 | 5-31 | 5-23 | 5-26 | 5-26 |
Weight (kg) | 70 ± 9.5 | 61 ± 6.6 | 66 ± 9.3 | 77 ± 12.2 | 70 ± 12.2 | 73 ± 11.8 |
Height (m) | 1.73 ± 0.04 | 1.56 ± 0.07 | 1.66 ± 0.1 | 1.75 ± 0.07 | 1.65 ± 0.05 | 1.69 ± 0.07 |
BMI (kg/m2) | 23.4 ± 2.6 | 25.3 ± 4.1 | 24.1 ± 3.2 | 25.3 ± 3.0 | 26.1 ± 3.9 | 25.8 ± 3.5 |
Fasting glucose (mg/dL) | 211 ± 79 | 177 ± 67 | 198 ± 75 | 190 ± 47 | 165 ± 62 | 175 ± 57 |
HbA1c (%) | 10.7 ± 1.7 | 9.6 ± 1.7 | 10.4 ± 1.8 | 10.4 ± 1.9 | 10.2 ± 2.0 | 10.3 ± 1.9 |
Data are shown as mean ± standard deviation (SD), except for diabetes duration, which is shown as the minimum and maximum number of years since diagnosis. M: male, F: female, BMI: body mass index.